BRM421

· BRIM Biotechnology Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BRM421, covering 2017-11-22 to 2021-10-21. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of BRM421 for Dry Eye Syndrome Treatment [Phase 2, Phase 3]